TissueGen® Inc., Dallas, Texas, has developed a breakthrough drug-delivery system that consists of polymers that can be integrated into implantable fabrics and medical devices. The polymer technology includes fiber extrusion at room temperature, which preserves the biological activity of therapeutic agents that might be deteriorated under high temperature extrusion techniques. Biomedical Structures LLC, Warwick, R.I., a developer of biomedical textiles, will integrate the polymers into drug-releasing medical devices, such as small diameter vascular grafts and stents, sutures and other implantable technologies. The unique polymer process can be used for many drugs and other therapeutics, such as enzymes and growth factors, and can be custom engineered for specific applications. Drugs are incorporated into the fabrics using commercially available polymer components, including polylactic acid and polydioxanone.
Absorbable polymers deliver medications
Advanced Textiles, Industry News | August 1, 2013 | By: ATA
You might also like...
Rotostitch raises $1 million in oversubscribed pre-seed funding round
Washington adopts new PFAS restrictions
Hohenstein Medical appoints Katie Brinkman biocompatibility program manager
EPA proposes shift in TSCA PFAS reporting policy, opens rule for public comment
NCTO applauds plans for duty-free reinstatement under CAFTA-DR